U.S. Online Retail and Ecommerce Stock News

Molson Coors Beverage (TAP) stock is reacting to fresh quarterly results, with first quarter sales of US$2,717.9 million and net income of US$151.3 million, along with a regular US$0.48 per share dividend declaration. See our latest analysis for Molson Coors Beverage. The first quarter update has come against a weak backdrop for the stock, with a 90 day share price return of a 16.67% decline and a 1 year total shareholder return of a 17.34% loss, so recent momentum has been fading despite...

Akebia Therapeutics, Inc. has reported past first-quarter 2026 results showing revenue of US$53.54 million versus US$57.34 million a year earlier, with net loss of US$9.05 million replacing prior net income of US$6.11 million. A recent proposal to increase authorized capital stock to 525,000,000 shares, including 500,000,000 common shares, adds a potential dilution and financing angle to Akebia’s weaker quarterly performance. Next, we’ll examine how the shift to a quarterly loss alongside...

Earlier this week, McEwen Inc. reported Q1 2026 results showing net income of US$33.4 million and revenue growth of very large versus a year earlier, reaffirmed its 2026 production guidance, and detailed progress on projects across North and South America. The company also advanced its long-term growth plan by activating a 50-50 joint venture on the New Pass gold property in Nevada, completing the Golden Lake Resources acquisition near its Gold Bar complex, and outlining a path to...

Credit card refresh and Fort Lauderdale build out take center stage JetBlue Airways (JBLU) has put its co branded JetBlue Premier World Elite Mastercard and Fort Lauderdale expansion at the heart of its current push to win and retain travelers after Spirit Airlines’ shutdown. The card now offers larger statement credits, status related tile bonuses and a sizable limited time TrueBlue points offer. Fort Lauderdale is set to see new routes, added frequencies and targeted perks for former Spirit...

If you are wondering whether GitLab at around US$25.92 is priced attractively or not, the key is understanding what the current valuation is actually baking in for the future. The stock has recently been volatile, with a 17.1% return over the last 7 days and 12.0% over the last 30 days, yet it still sits on a year to date return of 28.4% decline and a 1 year return of 47.7% decline. Recent coverage has focused on GitLab as a software platform positioned in a competitive developer tools...

In early May 2026, Nano Nuclear Energy Inc. announced a non-binding Memorandum of Understanding with Super Micro Computer, Inc. to explore integrating its KRONOS MMR microreactors with Supermicro’s AI server and data center platforms to create on-site nuclear-powered AI infrastructure. This collaboration highlights how pairing microreactors with AI data centers could create self-powered, grid-independent computing hubs aimed at meeting rapidly rising electricity needs from artificial...

Vertiv Holdings Co (VRT) has drawn fresh attention after reporting strong Q1 2026 results, highlighting 23% organic sales growth, a raised full year outlook, and growing exposure to AI data center infrastructure. See our latest analysis for Vertiv Holdings Co. That strong Q1 update sits on top of powerful momentum, with a 30 day share price return of 29.63% and a 90 day gain of 73.85%. The 1 year total shareholder return of 255.57% and very large 3 year total shareholder return signal how...

Bio-Rad Laboratories (BIO) stock is in focus after Q1 2026 results showed sales of US$592.1 million and a net loss of US$527.1 million, alongside weaker bioprocessing demand and cautious biotech spending. See our latest analysis for Bio-Rad Laboratories. The Q1 2026 net loss and reduced revenue outlook have been followed by a 7 day share price return of 8.14% decline and a year to date share price return of 15.71% decline, while the 1 year total shareholder return of 6.76% suggests longer...

Earlier this week, Ardelyx presented new long-term data at the National Kidney Foundation’s Spring Clinical Meetings showing that XPHOZAH (tenapanor) reduced serum phosphate in chronic kidney disease patients on dialysis without causing clinically meaningful changes in other serum electrolytes, nutrition markers, body mass, or blood pressure. This extended safety and efficacy profile for the first-in-class phosphate absorption inhibitor could strengthen XPHOZAH’s clinical positioning as an...

Why Williams Companies (WMB) is on investors’ radar today Williams Companies (WMB) has drawn attention after recent trading left the stock with a 1 day decline of about 1%, a 7 day decline around 4%, and mixed month and past 3 months returns. For investors watching the energy infrastructure space, this price action sits against a backdrop of annual revenue of about US$12.1b and net income of roughly US$2.8b, supported by a network of approximately 32,000 miles of pipelines. See our latest...

If you are wondering whether MetLife at around US$78.82 offers fair value or a margin of safety, this article explains what the current price might be indicating. The stock has returned 10.7% over the last 30 days, while the 1-year return is 3.8% and the 3-year return is 67.2%. These figures can influence how investors view both potential upside and risk. Recent coverage has highlighted MetLife's position as a major US insurance company. Investors have been focusing on how interest rate...

In the first quarter of 2026, Loar Holdings Inc. reported US$156.09 million in sales, up from US$114.66 million a year earlier, while net income fell to US$11.14 million from US$15.32 million and earnings per share from continuing operations eased to US$0.12 from US$0.16. The company paired these mixed profit figures with record adjusted EBITDA margins and an increase in full-year 2026 sales and adjusted EBITDA guidance, underscoring how pricing power and commercial aerospace strength are...

If you are wondering whether UGI is attractively priced or just a value trap, starting with the current share price and valuation checks can help frame the picture. UGI closed at US$32.32, with recent returns showing a 10.4% decline over 7 days, 12.7% over 30 days, 14.1% year to date, and 3.6% over 1 year. This is set against a 31.7% gain over 3 years and an 11.3% decline over 5 years. These mixed return figures sit alongside ongoing investor attention on UGI as a regulated utility and...

Why Sunoco (SUN) is on investors’ radar today Sunoco (SUN) has drawn attention after recent trading left the stock around $67.88, prompting investors to reassess how its fuel distribution, pipeline systems, refinery, and terminals businesses align with their income and total return goals. See our latest analysis for Sunoco. At a share price of $67.88, Sunoco has recently combined a 1-day share price return of 1.45% with a 90-day share price return of 17.85%, while its 5-year total shareholder...

Airbnb (ABNB) has wrapped up FY 2025 with fourth quarter revenue of US$2.8b and basic EPS of US$0.56, capping a year where trailing twelve month revenue reached US$12.2b and EPS came in at US$4.10. Over the past few quarters, revenue has moved from US$2.5b in Q4 2024 to US$4.1b in Q3 2025 before landing at US$2.8b in Q4 2025. Over the same stretch, quarterly EPS shifted from US$0.74 to US$2.25 and then to US$0.56, giving investors a clearer view of how profitability tracks Airbnb’s seasonally...

Advanced Energy Industries recently reported first-quarter 2026 results showing sales of US$511.0 million and diluted EPS from continuing operations of US$1.58, alongside confirming a US$0.10 quarterly dividend and updating second-quarter guidance. The company also completed a multi‑year share repurchase program, filed new shelf registrations for up to 3.0 million ESOP‑related shares, and signaled an active acquisition pipeline supported by what management describes as a strong balance...

LivaNova overview and recent share moves LivaNova (LIVN) has drawn investor attention after recent share price moves, with the stock showing double digit total returns over the past year, as well as solid gains over the past month and the past three months. See our latest analysis for LivaNova. The recent 7-day share price return of 18.01%, alongside a 16.96% year-to-date share price return and a 60.94% 1-year total shareholder return, indicates that momentum has been building over both...

Aehr Test Systems (AEHR) is back on traders’ radars after securing a record US$41 million order from an existing hyperscale AI customer, along with a backlog that nearly doubled year over year. See our latest analysis for Aehr Test Systems. Despite a 5.65% one day share price pullback to US$91.26 as traders react to mixed earnings and recent equity issuance, Aehr’s 30 day share price return of 81.61% and very large 1 year total shareholder return suggest momentum is still firmly positive. If...

In early May 2026, Insulet Corporation reported that first‑quarter revenue rose to US$761.7 million with net income of US$91.1 million, while also raising its full‑year 2026 GAAP revenue growth guidance to 22%–24% and projecting second‑quarter GAAP revenue growth of 21%–23%. At the same time, Insulet began enrolling participants in its EVOLVE pivotal trial for a fully closed‑loop insulin delivery system for type 2 diabetes, signaling an effort to extend its technology beyond current users...

Why Rowan Trollope’s appointment matters for DocuSign (DOCU) DocuSign (DOCU) has drawn fresh attention after appointing AI focused executive Rowan Trollope to its board of directors, a move tied closely to the company’s Intelligent Agreement Management ambitions. For you as an investor, this board change raises practical questions: how Trollope’s AI and cybersecurity background might influence DocuSign’s product roadmap, its competitive position in digital agreements, and how the market could...

In the first quarter of 2026, Moderna reported revenue of US$389 million versus US$108 million a year earlier, alongside a net loss of US$1.34 billion and basic loss per share of US$3.40, while also disclosing that it completed a US$1.34 billion share repurchase program launched in 2022. Alongside these results, Moderna’s publication of positive late-stage data for its mRNA-1010 flu vaccine and early-stage success in a hantavirus vaccine program underpins how its mRNA platform is being...

Earnings snapshot: what changed in Q1 2026 Centuri Holdings (CTRI) just posted first quarter 2026 results, reporting revenue of US$723.2 million compared with US$550.1 million a year earlier, a narrower net loss, and earnings that came in ahead of consensus expectations. See our latest analysis for Centuri Holdings. Centuri's Q1 2026 earnings beat, record US$6.5b backlog and reiterated guidance appear to have reset expectations. A recent 1 day share price return of negative 19.62% contrasts...

Fidelity National Information Services (FIS) has just wrapped up FY 2025 with fourth quarter revenue of US$2,812 million and basic EPS of US$0.99, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$2,599 million in Q4 2024 to US$2,812 million in Q4 2025, while basic EPS shifted from US$0.57 to US$0.99 over the same period. This gives a clear view of how the top line and per share earnings have tracked into this latest print. With...

Western Digital has launched a share swap program allowing investors to exchange Sandisk stock for NasdaqGS:WDC shares. The company plans to exit all remaining Sandisk holdings, completing the unwind of its historic equity link after the Sandisk spinoff. This move simplifies Western Digital's capital structure and removes cross ownership between the two storage businesses. For investors watching NasdaqGS:WDC, this step comes after a period of very strong share price performance. The stock...